Published on: June 24, 2020 at 09:30PM
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: dapagliflozin and saxagliptin
Sponsor: AstraZeneca
Not yet recruiting
https://ift.tt/2VeOggz
Wednesday, 24 June 2020
New diabetes clinical trial: To Assess the Safety of Fixed Dose Combination of Dapagliflozin and Saxagliptin in Indian Type 2 Diabetes Mellitus.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Nothing happens without a Reason
Make Something out of it.